FOLH1 and metastatic neoplasm: In this subset of 46 patients, 6 (13.0%) had no lesions, 6 (13.0%) had local recurrence, 14 (30.4%) had nodal recurrence and 20 (43.5%) had metastatic disease on PSMA PET/CT (Figure 1).